Clinical Trial Update: Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib [NA]

View source ↗

Summary

This completed multicenter trial investigates how long patients with chronic myeloid leukemia stay in molecular remission after stopping imatinib therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Chronic Myeloid Leukaemia | NA | Status: COMPLETED